featured
Medical-Focused Psychedelic Capitalism Will Enrich Elites While Continuing Criminalization Of Most Use (Op-Ed)

Published
1 month agoon

“Community-controlled decriminalization is a better path to mainstreaming psychedelics than relinquishing power to the medical industry and pharmaceutical cartels.”
By Kevin Walby, University of Winnepeg & Jamie Brownlee, Carleton University, via The Conversation
Once stigmatized and outlawed, psychedelics are moving from the counterculture to the mainstream. From Prince Harry’s use of psilocybin to National Football League quarterback Aaron Rodgers’s adventures with ayahuasca, our media is awash with accounts of their professed benefits.
Hundreds of universities around the world are now engaging in psychedelic research. And psychedelic legalization initiatives are taking hold.
Psychedelics are becoming big business. Just as private capital flooded the cannabis sector years ago, a psychedelic gold rush is underway.
Wealthy entrepreneurs are investing in the psychedelic industry while biotechnology startups are raising capital and running clinical trials on novel psychedelic molecules. Venture capitalists are eyeing the prospects of a new lucrative mass market.
Three causes for concern
To date, most debates about psychedelics have offered little critical analysis of their relationship to the political economy of modern capitalism and broader power structures. In our new book Psychedelic Capitalism, we make three central claims about the so-called psychedelic renaissance.
First, the medicalization of psychedelics is likely to restrict access and reinforce existing health and social inequalities.
Second, the corporatization of psychedelics will enable economic elites to dominate the market while appropriating the vast reservoir of knowledge built up by Indigenous communities, public institutions and underground researchers.
And third, rather than representing progressive drug reform, the limited legalization of select psychedelics for medical use will help to entrench and sustain the drug war and the criminalization of most drug use.
Ignoring community knowledge
Across North America, we’re seeing a medicalization of psychedelics, where a range of problems are presented as treatable by these substances. This is happening in a way that boosts corporate control of the process and pushes aside community and Indigenous knowledge.
We have seen this scenario play out in Australia. Substances such as psilocybin and MDMA are legally available, but only through a doctor’s prescription and at great financial cost—raising questions about equity, access and who these therapies are for.
Framing psychedelics as pharmaceutical commodities and individualized health-care solutions reinforces the prohibitionist narrative that these substances are unsuitable for use outside of the medical context. This narrative shifts attention away from how medicalized use might perpetuate a neoliberal ideology—locating mental “disorder” within an individual, rather than addressing more systemic causes such as poverty, inequality and social exclusion.
It also disregards centuries of traditions created by Indigenous community use, as well as the values of the psychedelic underground.
A system built on expensive individual therapy, medically trained gatekeepers and hyper-controlled clinical access is not the model that most advocates have envisioned.
A pill-only model for productivity and happiness
The foundations of psychedelic capitalism were largely created by public innovation at the public’s expense and are now in the process of being taken over by private capital.
Psychedelic conferences increasingly resemble corporate trade shows. The psychedelic tourism industry continues to expand and cater to elite clients. For-profit companies like Mind Medicine and Compass Pathways are eliminating psychotherapy from their treatment protocols and embracing a “pill-only” model favored by Big Pharma.
Psychedelics, including microdosing and psychedelic-assisted therapy, are marketed as a way for the general population to extract more work out of their already overworked lives, and to be happy about it in the process.
Companies are competing to capture intellectual property to harness profits from existing compounds and erect legal barriers around new chemicals and their applications.
The for-profit ketamine industry already offers a glimpse into the future of corporatized psychedelic therapy. This includes a lack of attention to risks, deceitful marketing and little consideration to therapeutic care.
There has been a surge of new patent applications (and granted patents) in the U.S. on substances such as psilocybin, LSD, DMT, 5-MeO DMT and mescaline that seek to secure exclusivity, monopolize supply chains and privatize knowledge that already exists in the public domain.
Psychedelics have been swept up into the well rehearsed capitalist playbook where private players are fabricating exclusionary rights over what are ultimately the products of collective human struggle and intellectual achievement.
Medical legalization of psychedelics
The medicalized approach to psychedelic mainstreaming also connects to drug law and policy.
Across North America, the biomedical approach is the main influence on drug law and the primary avenue for psychedelic access in most jurisdictions. This approach is widely supported by psychedelic capitalists who have a financial stake in medical legalization and want to limit legal access to anything outside of the medical-pharma frame.
In the United States, places like Oregon and Colorado have more holistic legal models that include elements of community control to prevent corporate capture. But most state initiatives remain limited in scope and are centered around medicalized therapy, particularly for military veterans. Even in Oregon, which has been lauded for its progressive drug policies, there has been an unmistakable drift toward medicalization.
Canada’s cannabis industry exemplifies how processes of legalization can become intertwined with the interests of corporate-dominated industries.
As Michael Devillaer, professor of psychiatry and behavioral neurosciences and author of Buzz Kill (2024), has explained, the cannabis industry has prioritized profit maximization, product promotion and increased consumption at the expense of public health concerns.
What is best for public interest?
As the medical legalization of psychedelics deepens, we are likely to see the intensification of criminal penalties for recreational and other uses.
In fact, police seizures of psychedelics like psilocybin in the U.S. have increased in recent years. Global arrests for the transportation of compounds such as ayahuasca, iboga and peyote have also increased.
These problems are likely to be exacerbated by systems of bifurcated scheduling, where a drug product is placed in a different class from the active ingredient or substance.
For example, if the U.S. Food and Drug Administration (FDA) were to approve psilocybin for depression or MDMA for PTSD, it is likely that only FDA-approved medicinal psilocybin and MDMA products would be rescheduled, while the substances themselves would continue to be prosecuted as restricted narcotics.
It is in the public interest to move beyond a myopic focus on medical legalization to a more open, decriminalized model of public access. An approach like this would not only mitigate the threats associated with corporate capture, it would also reduce the harms associated with criminalization and the war on drugs.
Community-controlled decriminalization is a better path to mainstreaming psychedelics than relinquishing power to the medical industry and pharmaceutical cartels that provide monopolized services to primarily affluent customers.
And treating drug use and dependence as a public health issue and incentivizing harm reduction and support services for at-risk populations would go a long way to mitigating the tragedies of the drug war.
Kevin Walby is a professor of criminal justice at the University of Winnepeg. Jamie Brownlee is a university instructor at the Department of Law and Legal Studies and Department of Geography and Environmental Studies at Carleton University.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
New Mexico Steps Up Enforcement Against Illicit Marijuana Operators With Hiring Of New Officers
-
Mike Tyson, Kevin Durant urging Trump to enact cannabis reform
-
Can Cannabis Drinks Be A Healthy Wellness Addition
-
‘Diet weed’ regulation fails again at Ohio Statehouse
-
Delaware to Commence Adult-Use Cannabis Sales on Aug. 1—831 Days Since Legalization
-
Study: Cannabis use could double risk of heart health
featured
New Mexico Steps Up Enforcement Against Illicit Marijuana Operators With Hiring Of New Officers

Published
55 minutes agoon
July 1, 2025
“We’ve become the mecca for ‘mota’…and we have to ask ourselves: Is that really what we want to be?”
By Patrick Lohmann, Source NM
More than three years after New Mexico legalized recreational marijuana, the state has become a national poster-child for recreational marijuana sales, and not in a good way, argues state Sen. Joseph Cervantes (D-Las Cruces).
“We’ve become the mecca for ‘mota’,” Cervantes said, using a slang term for marijuana common in New Mexico. “And we have to ask ourselves: Is that really what we want to be?”
He and other state lawmakers on the Legislature’s interim Courts and Criminal Justice Committee met Monday morning in Taos to discuss the proliferation of shops across the state, as well as their hopes for a new band of cannabis officers tasked with enforcing laws the Legislature enacted when it legalized recreational marijuana in April 2022.
Since legalizing cannabis, New Mexico retailers have sold about $1.7 billion combined in adult-use and medical cannabis, with the help of more than 1,600 licensed cannabis-related businesses such as retailers, testing labs and producers, according to a presentation from state Regulation and Licensing Department officials who spoke at the committee meeting.
While the industry is booming, high-profile examples of marijuana scofflaws in the state prompted lawmakers this session to pass House Bill 10, which funds the hiring and training of a new team of fully certified law enforcement officers empowered to bring criminal charges against those they suspect are lying about the source of the marijuana, exploiting their workers or altering the drug.
In the coming days, the state will advertise for a police chief in charge of the new crew of officers, according to Clay Bailey, superintendent of the New Mexico Regulation and Licensing Division. From there, they’ll hire up to six more officers.
“I really want seasoned people that know what they’re doing, [who have] dealt with drugs and things, and know what they’re getting into,” Bailey said of the new hires.
HB 10 also empowers the new officers to do more forensic accounting within the state’s system for tracking growers from seed to sale. The new hires free up inspectors to undertake audits to determine, for example, whether growers are lying about where their inventory came from or if they’re flooding the market with illegal products, Bailey said.
40 dispensaries and one grocery store
No limits exist in state law on the number of licenses that can be issued, and local jurisdictions also cannot ban cannabis dispensaries from operating, according to the Regulation and Licensing Division, though they can control how far apart they must be. Maestas suggested lawmakers change state law to grant control over licenses to towns and cities.
In Sunland Park, which borders Texas, where recreational marijuana is illegal, up to 40 cannabis retailers exist, state officials said Monday.
“This is just not healthy,” said Cervantes, whose senate district includes Sunland Park. “This is not a healthy environment for my community, for Sunland Park to have 36 [to] 40 dispensaries, one grocery store, maybe one liquor store.”
According to state data presented Monday, the town of less than 20,000 people has generated the second-highest amount of marijuana revenue in the state since April 2022. Regulators have tallied more than $127 million in recreational sales revenue from nearly 3 million transactions. Albuquerque, the highest-earning city, has generated more than $350 million.
According to a 2024 Pew Research Center study, Oklahoma has the highest number of marijuana dispensaries per capita in the country, with 36 per 100,000 residents. Cervantes estimated New Mexico to be about 30 per 100,000, which puts it far ahead of early marijuana adopters California and Colorado.
A coalition of about 100 cannabis businesses in June 2023 asked the governor to issue a pause on new licenses, saying they faced too much competition and chaos from a “flourishing” black market.
The issue has not gone away. Several lawmakers said they want to see the issue addressed in next year’s 30-day legislative session. Though budget-focused, New Mexico Gov. Michelle Lujan Grisham (D) could deem the topic germane.
“I hope you’ll ask the governor to fix what needs to be fixed,” Cervantes told the state cannabis regulators at the meeting, “and have us do that in the remaining administration in the 30-day session coming up.
The governor’s office did not immediately respond to a request for comment late Monday afternoon. However, in a town hall meeting in July in Española, the governor did acknowledge that the state needed to fix its process for licensing, in response to a resident’s complaint about the number of dispensaries.
“Expect the state to propose some restrictions,” the governor said, drawing applause, saying that the licensing “didn’t roll out the way we intended for it to roll out.”
This story was first published by Source NM.
Photo courtesy of Chris Wallis // Side Pocket Images.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

In the search of a healthier lifestyle…maybe a cannabis beverage can be added.
Millennials have lead the surge in the California sober movement, now they are embracing wellness culture, cannabis-infused beverages. The drinks are quickly becoming a go-to alternative to alcohol. But can they actually support your health—or are they more hype than help?
Cannabis drinks, especially low-dose THC and CBD seltzers or teas, promise relaxation, reduced stress, and better sleep. They offer a smoke-free, easily dosable way to consume cannabis—often infused with other wellness ingredients like adaptogens or nootropics.
RELATED: New Data About Cancer And Cannabis
This appeals especially to Millennials who are drinking less alcohol but still crave something social and calming. In fact, a 2022 National Institutes of Health survey reported record-high cannabis use among young adults aged 19–30, with many turning to edibles and beverages for a more controlled experience.
But is it actually healthy? That depends on how it’s used. According to the Mayo Clinic, while cannabis may help relieve anxiety, insomnia, and chronic pain, it also carries potential side effects—like dizziness, dry mouth, and interactions with other medications. The key is moderation and understanding what’s in your drink.
This is where microdosing comes in. Many cannabis beverages now contain just 2–5 mg of THC—enough to take the edge off without causing intoxication. For some, this low-dose approach promotes calm and better sleep without the hangover or mental fog associated with alcohol.
Still, not all drinks are created equal. Some products contain high sugar levels or unverified ingredients. It’s important to choose beverages with lab-tested THC or CBD levels and transparent labeling.
The U.S. Food and Drug Administration (FDA) has not yet approved cannabis-infused beverages for medical use, and warns that CBD and THC products may pose risks if misused—especially for people who are pregnant, breastfeeding, or taking medications. Always check with a healthcare provider before adding cannabis to your routine.
RELATED: Forget Ozempic Cannabis Can Help You Get a Summer Body
If you are looking at trying one, look for beverages with natural ingredients, low sugar, and clear THC/CBD content. Start low, go slow, and prioritize quality over trendiness.
cannabis drinks can be part of a balanced wellness lifestyle—if used mindfully. For Millennials seeking calmer evenings, better rest, or a social buzz without booze, these drinks offer a promising, low-impact alternative.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Delaware to Commence Adult-Use Cannabis Sales on Aug. 1—831 Days Since Legalization

Published
3 hours agoon
July 1, 2025
Delaware will be the 22nd state to launch adult-use cannabis sales when dispensaries open for business on Aug. 1, state regulators announced this week.
The Delaware Office of the Marijuana Commissioner (OMC) gave the green light on July 1 for the state’s 13 existing medical cannabis dispensaries, known as medical marijuana compassion centers, to transition to serving adult-use customers 21 years and older in a first-mover advantage beginning next month.
The forthcoming launch date comes more than two years—831 days to be exact—since former Delaware Gov. John Carney allowed the Delaware Marijuana Control Act to be enacted without his signature in April 2023.
Delaware Marijuana Commissioner Joshua Sanderlin, who was nominated in April 2025 to take the reins, is now overseeing the program rollout.
“The start of legal adult-use marijuana sales reflects the tireless efforts of our regulatory team and our strong partnerships with state agencies, industry stakeholders and community leaders,” Sanderlin said. “Our focus is on building a safe, equitable and accountable marijuana market that delivers real benefits to Delawareans. We will continue to issue conditional licenses to previously selected applicants to ensure they can begin operations once active.”
The OMC finalized regulations for a commercial marketplace in September 2024 under former Marijuana Commissioner Rob Coupe, who had originally hoped for a March 2025 sales launch with a strong focus on social equity licensees.
The OMC held lotteries in October 2024 and December 2024 to award 125 adult-use licenses to cultivators, manufacturers, retailers and testing labs, including for 30 new dispensaries, half of which were reserved for social equity applicants.
However, the spring 2025 sales launch was delayed when the Federal Bureau of Investigation (FBI) rejected the OCM’s application in March for a service code needed to initiate Delaware’s statutorily required criminal background checks via a fingerprinting system for new licensees. Existing medical operators have already undergone the background checks.
Delaware Gov. Matt Meyer signed legislation less than a month later to align state law with FBI standards for the service code, putting the adult-use sales launch via an equitable rollout back on track. However, the OCM did not specify when new licensees could enter the market in a July 1 press release announcing the Aug. 1 sales commencement.
“Delaware has taken a major step forward by launching a legal adult-use cannabis market that prioritizes equity, safety and accountability,” Meyer said. “This new industry will generate critical revenue to strengthen our schools, infrastructure and public health systems, while creating real opportunities for entrepreneurs. This revenue also gives us a powerful tool to invest in the communities most impacted by the war on drugs, addressing past wrongs and ensuring that the benefits of this new market reach every corner of our state. I’m proud we’re moving quickly and thoughtfully to build a cannabis market that reflects our values and expands opportunity for every Delawarean.”
Initially, there was no path for existing medical cannabis operators to transition to the expanded marketplace under the 2023 legalization legislation. However, the General Assembly passed follow-up legislation in 2024 to provide that pathway to help kickstart the adult-use program. Without medical cannabis companies providing products via established cultivation operations, the sales launch could have remained sidelined for years as new licensees build out their grow facilities.
Still, conversion licenses for medical cannabis companies to transition to adult-use operations came at a significant cost: $200,000 for cultivators, and $100,000 for manufacturers and retailers. The conversion fees resulted in $4 million in funding to support Delaware’s social equity applicant start-up grants, according to the OMC.
MariMed CEO Jon Levine, whose company acquired First State Compassion Center’s cultivation and processing facilities and two dispensaries in March, said he’s excited to participate in the expansion of Delaware’s cannabis program with the sales launch next month.
“Our Delaware business unit, First State Compassion, was the first licensed operator in the state 10 years ago, and since then, we have proudly served the state’s medical cannabis patients,” Levine said. “We are looking forward to opening our doors to many more residents and the nearly 30 million tourists who visit the state annually.”
In anticipation of the sales launch, MariMed has already improved its Wilmington and Lewes dispensaries to help ensure that an increase in customer traffic does not impact the experience and product selections that its medical cannabis patients have enjoyed up until this point, Levine said. The company has also begun scaling production at its cultivation and processing facilities to meet the expected rise in demand.
Delaware’s adult-use marketplace could provide $215 million in economic activity, including more than $40 million in annual state tax revenue, Spotlight Delaware reported earlier this year.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

New Mexico Steps Up Enforcement Against Illicit Marijuana Operators With Hiring Of New Officers

Mike Tyson, Kevin Durant urging Trump to enact cannabis reform

Can Cannabis Drinks Be A Healthy Wellness Addition

‘Diet weed’ regulation fails again at Ohio Statehouse

Delaware to Commence Adult-Use Cannabis Sales on Aug. 1—831 Days Since Legalization

Study: Cannabis use could double risk of heart health

RollPros Expands Offerings with New Packaging and Design Services for Pre-Roll Brands

Waco cannabis advocates create 'Craft Academy' to help businesses comply with THC law

The Congressional Cannabis Caucus Still Hasn’t Held A Meeting Six Months Into This Session, Co-Chair Says

Cannabis risks in spotlight as celebrity athletes push for marijuana reform

Trulieve Announces Registration Statement Filing

Cannabis use could double risk of heart death

Newly-Imposed Tax Hikes on Retail Cannabis Products Take Effect in Two States

Guns, marijuana found in Andover traffic stop

New Bipartisan Pennsylvania Bill Would Create Marijuana Regulatory Board Ahead Of Possible Adult-Use Legalization

House bill would “destroy” hemp industry, GOP senator says (Newsletter: July 1, 2025)

California's cannabis excise tax to rise to 19% July 1

Cannabis tax hike and parking rate increase take effect across California and Sacramento

Thailand starts banning the sale of cannabis without a prescription

Advocacy Organizations Call on Meta to End Censorship of Cannabis and Psychedelic Communities

Oceanside moving forward on retail cannabis stores – NBC 7 San Diego

Florida Removes Nearly 11,000 Hemp Product Packages for Violating Child-Protection Standards

The best strains for making hash

Nebraska Officials Propose Emergency Medical Cannabis Regulations

Alert: Department of Cannabis Control updates data dashboards with full data for 2023

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

5 best CBD creams of 2024 by Leafly

Free delta-9 gummies from Bay Smokes

EU initiative begins bid to open access to psychedelic therapies

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Mississippi city official pleads guilty to selling fake CBD products

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

May 2024 Leafly HighLight: Pink Runtz strain

5 best autoflower seed banks of 2024 by Leafly

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Discover New York’s dankest cannabis brands [September 2024]

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

6 best CBD gummies of 2024 by Leafly

5 best THC drinks of 2024 by Leafly

The Daily Hit: October 2, 2024

5 best delta-9 THC gummies of 2024 by Leafly

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair
Trending
-
California Cannabis Updates1 year ago
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year ago
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list11 months ago
5 best CBD creams of 2024 by Leafly
-
Bay Smokes1 year ago
Free delta-9 gummies from Bay Smokes
-
Business10 months ago
EU initiative begins bid to open access to psychedelic therapies
-
cbd1 year ago
New Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Mississippi Cannabis News1 year ago
Mississippi city official pleads guilty to selling fake CBD products
-
Breaking News1 year ago
Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man